The pharmaceutical giant Eli Lilly's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and ...

The drugmaker has joined an exclusive club primarily populated by technology giants, marking a significant achievement for the healthcare sector. Eli Lilly’s stock has surged more than 35% this year, ...

(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club ...

Eli Lilly’s weight-loss drugs have made it the first pharma company to hit a $1tn market valuation, a sharp turnaround from ...

Eli Lilly’s stock reached an all-time high of 1057.42 USD, marking a significant milestone for the pharmaceutical giant with a market capitalization now exceeding $940 billion. Over the past year, the ...

Digital health company Waltz Health said on Friday it has launched a ​program to offer popular weight-loss drugs from Novo ‌Nordisk and Eli Lilly directly to employers, bypassing traditional drug ...

US stocks turned higher Friday after a week of turbulence amid rising optimism for a December interest-rate cut, while bitcoin kept tumbling as AI worries continued to weigh on investors. While stocks ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...